Abstract
The increased understanding of complex biological processes in cancer initiation and progression has proportionately increased new anticancer drug development which is presently the top priority research field. The process of drug discovery and development is expensive, tedious, and unpredictable. Several steps are involved in this process, which requires strong multidisciplinary interaction. The duration of the procedure depends upon the validation of each step. Current data shows that out of the 10,000 newly screened compounds, only 250 enter preclinical testing and 5 enter clinical phase. However, only one compound gets regulatory approval. The percentage of success in developing a drug is very low, in spite of huge time spent and financial investments. Therefore, it is utmost important to refine every step of the drug development process so as to precisely evaluate the new compounds. The process of drug development consists of various phases like absorption, distribution, metabolism and excretion. All these phases can be precisely studied using several advanced tools and one such tool is non-invasive preclinical imaging. This chapter deals with various preclinical imaging modalities having huge potential in anticancer drug discovery. The imaging modalities discussed in details are positron emission tomography (PET), single photon emission computed tomography (SPECT), computed tomography (CT), optical, ultrasound and photoacoustic (US-PA) and spectral imaging. These modalities are complimentary to each other and need to be applied on the basis of information to be gathered. The common study/imaging protocol used in anticancer drug development has been mentioned with appropriate image data. The modalities such as photoacoustic and spectral imaging have huge potential for clinical applications due to their potential to characterise tissue and underlying pathophysiological differences.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aamir R, Chernoglazov A, Bateman C, Butler A, Butler P, Anderson N, Bell S, Panta R, Healy J, Mohr J (2014) Mars spectral molecular imaging of lamb tissue: data collection and image analysis. J Instrum 9:P02005
Akabani G, Cokgor I, Coleman RE, González Trotter D, Wong TZ, Friedman HS, Friedman AH, Garcia-Turner A, Herndon JE, Delong D, Mclendon RE, Zhao XG, Pegram CN, Provenzale JM, Bigner DD, Zalutsky MR (2000) Dosimetry and dose-response relationships in newly diagnosed patients with malignant gliomas treated with Iodine-131-labeled anti-tenascin monoclonal antibody 81C6 therapy. Int J Radiat Oncol Biol Phys 46:947–958
Albanese A, Tang PS, Chan WC (2012) The effect of nanoparticle size, shape, and surface chemistry on biological systems. Annu Rev Biomed Eng 14:1–16
Almuhaideb A, Papathanasiou N, Bomanji J (2011) 18F-FDG PET/CT imaging in. Oncology 31(1):3–13
Anderson CR, Rychak JJ, Backer M, Backer J, Ley K, Klibanov AL (2010a) ScVEGF microbubble ultrasound contrast agents: a novel probe for ultrasound molecular imaging of tumor angiogenesis. Investig Radiol 45(10):579–585
Anderson N, Butler A, Scott N, Cook N, Butzer J, Schleich N, Firsching M, Grasset R, De Ruiter N, Campbell M (2010b) Spectroscopic (multi-energy) CT distinguishes iodine and barium contrast material in MICE. Eur Radiol 20:2126–2134
Anderson NG, Butler AP (2014) Clinical applications of spectral molecular imaging: potential and challenges. Contrast Media Mol Imaging 9:3–12
Ballabriga R, Alozy J, Blaj G, Campbell M, Fiederle M, Frojdh E, Heijne E, Llopart X, Pichotka M, Procz S (2013) The Medipix3RX: a high resolution, zero dead-time pixel detector readout chip allowing spectroscopic imaging. J Instrum 8:C02016
Barkhof F, Simon JH, Fazekas F, Rovaris M, Kappos L, De Stefano N, Polman CH, Petkau J, Radue EW, Sormani MP, Li DK, O’connor P, Montalban X, Miller DH, Filippi M (2012) MRI monitoring of immunomodulation in relapse-onset multiple sclerosis trials. Nat Rev Neurol 8(1):13–21
Barr RG (2017) How to develop a contrast-enhanced ultrasound program. J Ultrasound Med 36(6):1225–1240
Bateman CJ, Mcmahon J, Malpas A, De Ruiter N, Bell S, Butler AP, Butler PH, Renaud PF (2013) Segmentation enhances material analysis in multi-energy CT: a simulation study. In: 28th International Conference of Image and Vision Computing New Zealand (IVCNZ), 2013. IEEE, pp 190–195
Bateman CJ, Rajendran K, De Ruiter NJ, Butler AP, Butler PH, Renaud PF (2015) The hidden K-edge signal in K-edge imaging. arXiv preprint arXiv:1506.04223
Belhocine T, Steinmetz N, Hustinx R, Bartsch P, Jerusalem G, Seidel L, Rigo P, Green A (2002) Increased uptake of the apoptosis-imaging agent99mTc recombinant human annexin V in human tumors after one course of chemotherapy as a predictor of tumor response and patient prognosis. Clin Cancer Res 8(9):2766–2774
Bergers G, Benjamin LE (2003) Tumorigenesis and the angiogenic switch. Nat Rev Cancer 3(6):401–410
Berridge MS, Heald DL (1999) In vivo characterization of inhaled pharmaceuticals using quantitative positron emission tomography. J Clin Pharmacol 39(S1):25S–29S
Blankenberg FG, Backer MV, Levashova Z, Patel V, Backer JM (2006) In vivo tumor angiogenesis imaging with site-specific labeled99mTc-HYNIC-VEGF. Eur J Nucl Med Mol Imaging 33(7):841–848
Cai W, Rao J, Gambhir SS, Chen X (2006) How molecular imaging is speeding up antiangiogenic drug development. Mol Cancer Ther 5(11):2624–2633
Cerussi AE, Tanamai VW, Mehta RS, Hsiang D, Butler J, Tromberg BJ (2010) Frequent optical imaging during breast Cancer neoadjuvant chemotherapy reveals dynamic tumor physiology in an individual patient. Acad Radiol 17(8):1031–1039
Chandrani P, Prabhash K, Prasad R, Sethunath V, Ranjan M, Iyer P, Aich J, Dhamne H, Iyer DN, Upadhyay P, Mohanty B, Chandna P, Kumar R, Joshi A, Noronha V, Patil V, Ramaswamy A, Karpe A, Thorat R, Chaudhari P, Ingle A, Choughule A, Dutt A (2017) Drug-sensitive FGFR3 mutations in lung adenocarcinoma. Ann Oncol 28:597–603
Chang CH, Hsu WC, Wang CY, Jan ML, Tsai TH, Lee TW, Lynn SG, Yeh CH, Chang TJ (2007) Longitudinal microSPECT/CT imaging and pharmacokinetics of synthetic luteinizing hormone-releasing hormone (LHRH) vaccine in rats. Anticancer Res 27(5A):3251–3258
Chen X, Park R, Shahinian AH, Tohme M, Khankaldyyan V, Bozorgzadeh MH, Bading JR, Moats R, Laug WE, Conti PS (2004) 18F-labeled RGD peptide: initial evaluation for imaging brain tumor angiogenesis. Nucl Med Biol 31(2):179–189
Cheung MC, Maceachern JA, Haynes AE, Meyer RM, Imrie K (2009) 131I-tositumomab in lymphoma. Curr Oncol 16(5):32–47
Choi W, Park E-Y, Jeon S, Kim C (2018) Clinical photoacoustic imaging platforms. Biomed Eng Lett 8:1–17
Chrastina A, Valadon P, Massey KA, Schnitzer JE (2010) Lung vascular targeting using antibody to aminopeptidase P: CT-SPECT imaging, biodistribution and pharmacokinetic analysis. J Vasc Res 47(6):531–543
Cohen CM (2003) A path to improved pharmaceutical productivity. Nat Rev Drug Discov 2(9):751–753
Cole LE, Ross RD, Tilley JM, Vargo-Gogola T, Roeder RK (2015) Gold nanoparticles as contrast agents in x-ray imaging and computed tomography. Nanomedicine 10:321–341
Contessa JN, Bhojani MS, Freeze HH, Ross BD, Rehemtulla A, Lawrence TS (2010) Molecular imaging of N-linked glycosylation suggests glycan biosynthesis is a novel target for cancer therapy. Clin Cancer Res 16(12):3205–3214
Curtis TE, Roeder RK (2017) Calibration methods influence quantitative material decomposition in photon-counting spectral CT, SPIE
Das S, Gurav S, Soni V, Ingle A, Mohanty BS, Chaudhari P, Bendale K, Dholam K, Bellare JR (2018) Osteogenic nanofibrous coated titanium implant results in enhanced osseointegration: in vivo preliminary study in a rabbit model. Tissue Eng Regen Med 15:231–247
Decristoforo C, Faintuch-Linkowski B, Rey A, Von Guggenberg E, Rupprich M, Hernandez-Gonzales I, Rodrigo T, Haubner R (2006) [99mTc]HYNIC-RGD for imaging integrin alphavbeta3 expression. Nucl Med Biol 33(8):945–952
Deshpande N, Ren Y, Foygel K, Rosenberg J, Willmann JK (2010) Longitudinal assessment of expression levels of tumor angiogenic markers with molecular ultrasound imaging. Mol Imaging Biol
Diekmann F, Bick U (2007) Tomosynthesis and contrast-enhanced digital mammography: recent advances in digital mammography. Eur Radiol 17:3086–3092
Difilippo FP (2008) Design and performance of a multi-pinhole collimation device for small animal imaging with clinical SPECT and SPECT-CT scanners. Phys Med Biol 53(15):4185–4201
DiMasi JA, Feldman L, Seckler A, Wilson A (2010) Trends in risks associated with new drug development: success rates for investigational drugs
DiMasi JA, Grabowski HG, Hansen RW (2016) Innovation in the pharmaceutical industry: new estimates of R&D costs. J Health Econ 47:20–33
DiMasi JA, Hansen RW, Grabowski HG (2003) The price of innovation: new estimates of drug development costs. J Health Econ 22(2):151–185
Durkee BY, Mudd SR, Roen CN, Clipson L, Newton MA, Weichert JP, Pickhardt PJ, Halberg RB (2008) Reproducibility of tumor volume measurement at MicroCT colonography in living mice. Acad Radiol 15:334–341
Fani M, Psimadas D, Zikos C, Xanthopoulos S, Loudos GK, Bouziotis P, Varvarigou AD (2006) Comparative evaluation of linear and cyclic 99mTc-RGD peptides for targeting of integrins in tumor angiogenesis. Anticancer Res 26:431–434
Feugier P, Hoof AV, Sebban C, Solal-Celigny P, Bouabdallah R, Fermé C, Christian B, Lepage E, Tilly H, Morschhauser F, Gaulard P, Salles G, Bosly A, Gisselbrecht C, Reyes F, Coiffier B (2005) Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d’Etude des Lymphomes de l’Adulte. J Clin Oncol 23:4117–4126
Fischman AJ, Alpert NM, Rubin RH (2002) Pharmacokinetic imaging: a noninvasive method for determining drug distribution and action. Clin Pharmacokinet 41:581–602
Fomchenko EI, Holland EC (2006) Mouse models of brain tumors and their applications in preclinical trials. Clin Cancer Res 12:5288–5297
Foster FS, Hossack J, Adamson SL (2011) Micro-ultrasound for preclinical imaging. Interface focus 1:576–601
Frank R, Hargreaves R (2003) Clinical biomarkers in drug discovery and development. Nat Rev Drug Discov 2(7):566–580
Fushiki H, Kanoh-Azuma T, Katoh M, Kawabata K, Jiang J, Tsuchiya N, Satow A, Tamai Y, Hayakawa Y (2009) Quantification of mouse pulmonary cancer models by microcomputed tomography imaging. Cancer Sci 100:1544–1549
Gabriel M, Muehllechener P, Decristoforo C, Von Guggenberg E, Kendler D, Prommegger R, Profanter C, Moncayo R, Virgolini I (2005) 99mTc-EDDA/HYNIC-Tyr(3)-octreotide for staging and follow-up of patients with neuroendocrine gastro-entero-pancreatic tumors. Q J Nucl Med Mol Imaging 11:3953–3957
Giand N (2018) Whales, scales and moons — July’s best science images. Nature 560:281
Gioux S, Choi HS, Frangioni JV (2010) Image-guided surgery using invisible near-infrared light: fundamentals of clinical translation. Mol Imaging 9:7290
Lacan G, Kesner AL, Gangloff A, Zheng L, Czernin J, Melega WP, Silverman DHS (2005) Synthesis of 2-[(2-chloro-2′-[18F]fluoroethyl)amino]-2H-1,3,2-oxazaphosphorinane-2-oxide (18F-fluorocyclophosphamide), a potential tracer for breast tumor prognostic imaging with PET. J Labelled Compd Radiopham 48:635–643
Graham KC, Wirtzfeld LA, Mackenzie LT, Postenka CO, Groom AC, Macdonald IC, Fenster A, Lacefield JC, Chambers AF (2005) Three-dimensional high-frequency ultrasound imaging for longitudinal evaluation of liver metastases in preclinical models. Cancer Res 65:5231–5237
Grange C, Geninatti-Crich S, Esposito G, Alberti D, Tei L, Bussolati B, Aime S, Camussi G (2010) Combined delivery and magnetic resonance imaging of neural cell adhesion molecule-targeted doxorubicin-containing liposomes in experimentally induced Kaposi’s sarcoma. Cancer Res 70:2180–2190
Guibal A, Taillade L, Mulé S, Comperat E, Badachi Y, Golmard JL, Guillou-Buffello LE, Rixe O, Bridal SL, Lucidarme O (2010) Noninvasive contrast-enhanced US quantitative assessment of tumor microcirculation in a murine model: effect of discontinuing anti-VEGF therapy. Radiology 254:420–429
Hajra KM, Liu JR (2004) Apoptosome dysfunction in human cancer. Apoptosis 9:691–704
Hajra KM, Tan L, Liu JR (2008) Defective apoptosis underlies chemoresistance in ovarian cancer. Adv Exp Med Biol 622:197–208
Hasegawa S, Furukawa T, Saga T (2010) Molecular MR imaging of cancer gene therapy: ferritin transgene reporter takes the stage. Magn Reson Med Sci 9:37–47
Häusler A, Allegrini PR, Biollaz M, Batzl C, Scheidegger E, Bhatnagar AS (1996) CGP 53153: a new potent inhibitor of 5α-reductase. J Steroid Biochem Mol Biol 57:187–195
He C, Hu Y, Yin L, Tang C, Yin C (2010) Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles. Biomaterials 31:3657–3666
Hendrikse NH, Franssen EJF, Van Der Graaf WTA, Vaalburg W, De Vries EGE (1999) Visualization of multidrug resistance in vivo. Eur J Nucl Med 26:283–293
Hodé Y, Reimold M, Demazières A, Reischl G, Bayle F, Nuss P, Hameg A, Dib M, Macher JP (2005) A positron emission tomography (PET) study of cerebral dopamine D 2 and serotonine 5-HT2A receptor occupancy in patients treated with cyamemazine (Tercian). Psychopharmacology 180:377–384
Hoyt K, Warram JM, Umphrey H, Belt L, Lockhart ME, Robbin ML, Zinn KR (2010) Determination of breast cancer response to bevacizumab therapy using contrast-enhanced ultrasound and artificial neural networks. J Ultrasound Med 29:577–585
Hsueh W-A, Kesner AL, Gangloff A, Pegram MD, Beryt M, Czernin J, Phelps ME, Silverman DHS (2006) Predicting chemotherapy response to paclitaxel with 18F-Fluoropaclitaxel and PET. J Nucl Med 47:1995–1999
Hu S, Kiesewetter DO, Zhu L, Guo N, Gao H, Liu G, Hida N, Lang L, Niu G, Chen X (2012) Longitudinal PET imaging of doxorubicin-induced cell death with 18F-annexin v. Mol Imaging Biol 14:762–770
Huang G, Yang S, Yuan Y, Xing D (2011) Combining x-ray and photoacoustics for in vivo tumor imaging with gold nanorods. Appl Phys Lett 99:123701
Huynh AS, Abrahams DF, Torres MS, Baldwin MK, Gillies RJ, Morse DL (2011) Development of an orthotopic human pancreatic cancer xenograft model using ultrasound guided injection of cells. PLoS One 6:e20330
Jadvar H, Colletti P, Delgado-Bolton R, Esposito G, Krause B, Iagaru A, Nadel H, Quinn D, Rohren E, Subramaniam R, Zukotynski K, Kauffman J, Ahuja S, Griffeth LK (2017) Appropriate use criteria for18F-FDG PET/CT in restaging and treatment response assessment of malignant disease. J Nucl Med 58:2026–2037
Jager PL, Plaat BEC, De Vries EGE, Molenaar WM, Vaalburg W, Piers DA, Hoekstra HJ (2000) Imaging of soft-tissue tumors using L-3-[iodine-123]iodo-α-methyl- tyrosine single photon emission computed tomography: comparison with proliferative and mitotic activity, cellularity, and vascularity. Clin Cancer Res 6(6):2252–2259
Jindal A, Mathur A, Pandey U, Sarma HD, Chaudhari P, Dash A (2014) Development of 68Ga-labeled fatty acids for their potential use in cardiac metabolic imaging. J Labelled Comp Radiopharm 57:463–469
Johnson JI, Decker S, Zaharevitz D, Rubinstein LV, Venditti JM, Schepartz S, Kalyandrug S, Christian M, Arbuck S, Hollingshead M, Sausville EA (2001) Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials. Br J Cancer 84:1424–1431
Jolly C, Jeanny JC, Behar-Cohen F, Laugier P, Saïed A (2005) High-resolution ultrasonography of subretinal structure and assessment of retina degeneration in rat. Exp Eye Res 81:592–601
Jose J, Manohar S, Kolkman RG, Steenbergen W, Van Leeuwen TG (2009) Imaging of tumor vasculature using Twente photoacoustic systems. J Biophotonics 2:701–717
Juhász C, Dwivedi S, Kamson DO, Michelhaugh SK, Mittal S (2014) Comparison of amino acid positron emission tomographic radiotracers for molecular imaging of primary and metastatic brain tumors. Mol Imaging 13:1–16
Jung JH, Choi Y, Im KC (2016) PET/MRI: technical challenges and recent advances. Nucl Med Mol Imaging 50:3–12
Kang BH, Siegelin MD, Plescia J, Raskett CM, Garlick DS, Dohi T, Lian JB, Stein GS, Languino LR, Altieri DC (2010) Preclinical characterization of mitochondria-targeted small molecule Hsp90 inhibitors, gamitrinibs, in advanced prostate cancer. Clin Cancer Res 16:4779–4788
Kartachova M, Haas RLM, Valdés Olmos RA, Hoebers FJP, Van Zandwijk N, Verheij M (2004) In vivo imaging of apoptosis by 99mTc-Annexin V scintigraphy: visual analysis in relation to treatment response. Radiother Oncol 72(3):333–339
Kartachova MS, Valdés Olmos RA, Haas RLM, Hoebers FJP, Van Den Brekel MW, Van Zandwijk N, Herk MV, Verheij M (2006) Mapping of treatment-induced apoptosis in normal structures:99mTc-Hynic-rh-annexin V SPECT and CT image fusion. Eur J Nucl Med Mol Imaging 33:893–899
Katz R (2004) Biomarkers and surrogate markers: an FDA perspective. NeuroRx 1:185–195
Kesner AL, Hsueh WA, Htet NL, Pio BS, Czernin J, Pegram MD, Phelps ME, Silverman DHS (2007) Biodistribution and predictive value of 18F-Fluorocyclophosphamide in mice bearing human breast Cancer xenografts. J Nucl Med 48:2021–2027
Kiesewetter DO, Jagoda EM, Kao CHK, Ma Y, Ravasi L, Shimoji K, Szajek LP, Eckelman WC (2003) Fluoro-, bromo-, and iodopaclitaxel derivatives: synthesis and biological evaluation. Nucl Med Biol 30:11–24
Kim JY, Park H, Lee JC, Kim KM, Lee KC, Ha HJ, Choi TH, An GI, Cheon GJ (2009) A simple cu-64 production and its application of cu-64 ATSM. Appl Radiat Isot 67:1190–1194
Kulkarni SA, Feng S-S (2013) Effects of particle size and surface modification on cellular uptake and biodistribution of polymeric nanoparticles for drug delivery. Pharm Res 30:2512–2522
Kumar P, Singh B, Ghai A, Hazari PP, Mittal BR, Mishra AK (2015) Development of a single vial kit formulation of [99mTc]-labeled doxorubicin for tumor imaging and treatment response assessment-preclinical evaluation and preliminary human results. J Label Compd Radiopharm 58:242–249
Kurdziel KA, Kiesewetter DO, Carson RE, Eckelman WC, Herscovitch P (2003) Biodistribution, radiation dose estimates, and in vivo Pgp modulation studies of 18F-paclitaxel in nonhuman primates. J Nucl Med 44:1330–1339
Kuwert T, Probst-Cousin S, Woesler B, Morgenroth C, Lerch H, Matheja P, Palkovic S, Schafers M, Wassmann H, Gullotta F, Schober O (1997) Iodine-123-alpha-methyl tyrosine in gliomas: correlation with cellular density and proliferative activity. J Nucl Med 38:1551–1555
Lappin G, Garner RC (2003) Big physics, small doses: the use of AMS and PET in human microdosing of development drugs. Nat Rev Drug Discov 2:233–240
Lee KC, Hamstra DA, Bhojani MS, Khan AP, Ross BD, Rehemtulla A (2007) Noninvasive molecular imaging sheds light on the synergy between 5-fluorouracil and TRAIL/Apo2L for cancer therapy. Clin Cancer Res 13:1839–1846
Li L, Zhu L, Ma C, Lin L, Yao J, Wang L, Maslov K, Zhang R, Chen W, Shi J (2017) Single-impulse panoramic photoacoustic computed tomography of small-animal whole-body dynamics at high spatiotemporal resolution. Nature Biomed Eng 1:0071
Liersch T, Meller J, Kulle B, Behr TM, Markus P, Langer C, Ghadimi BM, Wegener WA, Kovacs J, Horak ID, Becker H, Goldenberg DM (2005) Phase II trial of carcinoembryonic antigen radioimmunotherapy with 131I-labetuzumab after salvage resection of colorectal metastases in the liver: five-year safety and efficacy results. J Clin Oncol 23:6763–6770
Liu M, Chen Z, Zabihian B, Sinz C, Zhang E, Beard PC, Ginner L, Hoover E, Minneman MP, Leitgeb RA (2016) Combined multi-modal photoacoustic tomography, optical coherence tomography (OCT) and OCT angiography system with an articulated probe for in vivo human skin structure and vasculature imaging. Biomed Opt Express 7:3390–3402
Lyons SK (2005) Advances in imaging mouse tumour models in vivo. J Pathol 205:194–205
Madsen MT (2007) Recent advances in SPECT imaging. J Nucl Med 48:661–673
Mahmoodi N, Motameda N, Paylakhic SH, Mahmoodid NO (2015) Comparing the effect of Silybin and Silybin advanced™ on viability and HER2 expression on the human breast Cancer SKBR3 cell line by no serum starvation. Iran J Pharm Res 14:521–530
Mallidi S, Watanabe K, Timerman D, Schoenfeld D, Hasan T (2015) Prediction of tumor recurrence and therapy monitoring using ultrasound-guided photoacoustic imaging. Theranostics 5:289
Mandlik SK, Ranpise NS, Mohanty BS, Chaudhari PR (2018) A coupled bimodal SPECT-CT imaging and brain kinetics studies of zolmitriptan-encapsulated nanostructured polymeric carriers. Drug Deliv Transl Res 8:797–805
Mathur A, Sharma AK, Murhekar V, Mallia MB, Pawade S, Sarma H, Chaudhari P, Sachdev S, Banerjee S (2015) Syntheses and biological evaluation of 99m Tc-HYNIC-fatty acid complexes for myocardial imaging. RSC Adv 5:93374–93385
Mendoza-Sánchez AN, Ferro-Flores G, Ocampo-GarcÃa BE, Morales-Avila E, RamÃrez FDM, De León-RodrÃguez LM, Santos-Cuevas CL, Medina LA, Rojas-Calderón EL, Camacho-López MA (2010) Lys3-bombesin conjugated to 99mTc-labelled gold nanoparticles for in vivo gastrin releasing peptide-receptor imaging. J Biomed Nanotechnol 6:375–384
Mercep E, Jeng G, Morscher S, Li P-C, Razansky D (2015) Hybrid optoacoustic tomography and pulse-echo ultrasonography using concave arrays. IEEE Trans Ultrason Ferroelectr Freq Control 62:1651–1661
Miller DH (2002) Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance. Brain 125:1676–1695
Minckwitz GV, Procter M, Azambuja ED, Zardavas D, Benyunes M, Viale G, Suter T, Arahmani A, Rouchet N, Clark E, Knott A, Lang I, Levy C, Yardley DA, Bines J, Gelber RD, Piccart M, Baselga J (2017) Adjuvant Pertuzumab and Trastuzumab in early HER2-positive breast Cancer. N Engl J Med 377:122–131
Mishani E, Abourbeh G, Eiblmaier M, Anderson C (2008) Imaging of EGFR and EGFR tyrosine kinase overexpression in tumors by nuclear medicine modalities. Curr Pharm Des 14:2983–2998
Moghiseh M (2018) Optimization of spectral CT for novel applications of nanoparticles. A thesis submitted in partial fulfilment of the requirements for the degree of Doctor of Philosophy in Medical Physics, University of Otago
Moghiseh M, Lowe C, Lewis JG, Kumar D, Butler A, Anderson N, Raja A (2018) Spectral photon-counting molecular imaging for quantification of monoclonal antibody-conjugated gold nanoparticles targeted to lymphoma and breast cancer: an in vitro study. Contrast Media Mol Imaging 2018:2136840
Morgan TM, Pitts TEM, Gross TS, Poliachik SL, Vessella RL, Corey E (2008) RAD001 (Everolimus) inhibits growth of prostate cancer in the bone and the inhibitory effects are increased by combination with docetaxel and zoledronic acid. Prostate 68:861–871
Moros M, Hernaez B, Garet E, Dias JT, Saez B, Grazu V, Ndez AGL-F, Alonso C, Fuente JMDL (2012) Monosaccharides versus PEG-functionalized NPs influence in the cellular uptake. ACS Nano 6:1565–1577
Moseley CK, Carlin SM, Neelamegam R, Hooker JM (2012) An efficient and practical radiosynthesis of [11C]temozolomide. Org Lett 14:5872–5875
Mouchess ML, Sohara Y, Nelson MD, Declerck YA, Moats RA (2006) Multimodal imaging analysis of tumor progression and bone resorption in a murine cancer model. J Comput Assist Tomogr 30:525–534
Needles A, Heinmiller A, Sun J, Theodoropoulos C, Bates D, Hirson D, Yin M, Foster FS (2013) Development and initial application of a fully integrated photoacoustic micro-ultrasound system. IEEE Trans Ultrason Ferroelectr Freq Control 60:888–897
Niederhauser JJ (2004) Real-time biomedical optoacoustic imaging. ETH Zurich
Niu G, Sun X, Cao Q, Courter D, Koong A, Le QT, Gambhir SS, Chen X (2010) Cetuximab-based immunotherapy and radioimmunotherapy of head and neck squamous cell carcinoma. Clin Cancer Res 16:2095–2105
Ntziachristos V (2010) Going deeper than microscopy: the optical imaging frontier in biology. Nat Methods 7:603
O’connor JPB, Jackson A, Parker GJM, Jayson GC (2007) DCE-MRI biomarkers in the clinical evaluation of antiangiogenic and vascular disrupting agents. British J Cancer 96:189–195
O’connor, M. K. & Kemp, B. J. 2006. Single-photon emission computed tomography/computed tomography: basic instrumentation and innovations
Ohta S, Lai EW, Morris JC, Bakan DA, Klaunberg B, Cleary S, Powers JF, Tischler AS, Abu-Asab M, Schimel D, Pacak K (2006) MicroCT for high-resolution imaging of ectopic pheochromocytoma tumors in the liver of nude mice. Int J Cancer 9:2236–2241
Panta R, Bell ST, Healy J, Aamir R, Bateman C, Moghiseh M, Butler A, ANDERSON N (2018) Element-specific spectral imaging of multiple contrast agents: a phantom study. J Instrum 13:T02001
Pardridge WM (2007) Blood-brain barrier delivery. Drug Discov Today 12(1–2):54–61
Peck M, Pollack HA, Friesen A, Muzi M, Shoner SC, Shankland EG, Fink JR, Armstrong JO, Link JM, Krohn KA (2015) Applications of PET imaging with the proliferation marker [18F]-FLT. Q J Nucl Med Mol Imaging 59:95–104
Pigula M, Huang HC, Mallidi S, Anbil S, Liu J, Mai Z, Hasan T (2018) Size-dependent tumor response to photodynamic therapy and irinotecan monotherapies revealed by longitudinal ultrasound monitoring in an Orthotopic pancreatic Cancer model. Photochem Photobiol 95:378–386
Piscaglia F, Bolondi L (2006 Sep) The safety of Sonovue in abdominal applications: retrospective analysis of 23188 investigations. Ultrasound Med Biol 32(9):1369–1375
Pochon S, Tardy I, Bussat P, Bettinger T, Brochot J, von Wronski M, Passantino L, Schneider M (2010) BR55: a Lipopeptide-based VEGFR2-targeted ultrasound contrast agent for molecular imaging of angiogenesis. Investig Radiol 45(2):89–95
Prabhu S, Goda JS, Mutalik S, Mohanty BS, Chaudhari P, Rai S, Udupa N, RAO BSS (2017) A polymeric temozolomide nanocomposite against orthotopic glioblastoma xenograft: tumor-specific homing directed by nestin. Nanoscale 9:10919–10932
Prajapati SI, Keller C (2011) Contrast enhanced vessel imaging using MicroCT. J Vis Exp 47:2377
Pysz MA, Willmann JK (2011) Targeted contrast-enhanced ultrasound: an emerging Technology in Abdominal and Pelvic Imaging. Gastroenterology 140(3):785–790.e6
Pysz MA, Foygel K, Rosenberg J, Gambhir SS, Schneider M, Willmann JK (2010) Antiangiogenic Cancer therapy: monitoring with molecular US and a clinically translatable contrast agent (BR55). Radiology 256:519–527
Qiao R, Yang C, Gao M (2009) Superparamagnetic iron oxide nanoparticles: from preparations to in vivo MRI applications. Royal Soc Chem 19:6274–6293
Rao PS, Thakur ML, Pallela V, Patti R, Reddy K, Li H, Sharma S, Pham HL, Diggles L, Minami C, Marcus CS (2001) 99mTc labeled VIP analog: evaluation for imaging colorectal cancer. Nucl Med Biol 28:445–450
Reddy N, Hernandez-Ilizaliturri FJ, Deeb G, Roth M, Vaughn M, Knight J, WALLACE P, CZUCZMAN MS (2008) Immunomodulatory drugs stimulate natural killer-cell function, alter cytokine production by dendritic cells, and inhibit angiogenesis enhancing the anti-tumour activity of rituximab in vivo. Br J Haematol 140:36–45
Rice SL, Roney CA, Daumar P, Lewis JS (2011) The next generation of positron emission tomography radiopharmaceuticals in oncology. Semin Nucl Med 41(4):265–282
Rodrigues M, Traub-Weidinger T, Li S, Ibi B, Virgolini I (2006) Comparison of 111In-DOTA-DPhe1-Tyr 3-octreotide and 111In-DOTA-lanreotide scintigraphy and dosimetry in patients with neuroendocrine tumours. Eur J Nucl Med Mol Imaging 33:532–540
Ronaldson J, Butler A, Anderson N, Zainon R, Butler P. (2011) The performance of MARS-CT using Medipix3 for spectral imaging of soft-tissue. In: Nuclear Science Symposium and Medical Imaging Conference (NSS/MIC), 2011 IEEE, 2011. IEEE, pp 4002–4008
Rudin M (2007) Imaging readouts as biomarkers or surrogate parameters for the assessment of therapeutic interventions. Eur Radiol 17:2441–2457
Rudin M, Weissleder R (2003) Molecular imaging in drug discovery and development. Nat Rev Drug Discov 2(2):123–131
Saleem A, Harte RJ, Matthews JC, Osman S, Brady F, Luthra SK, Brown GD, Bleehen N, Connors T, Jones T, Price PM, Aboagye EO (2001) Pharmacokinetic evaluation of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide in patients by positron emission tomography. J Clin Oncol 19:1421–1429
Schambach SJ, Bag S, Schilling L, Groden C, Brockmann MA (2010) Application of micro-CT in small animal imaging. Methods 50:2–13
Scheepbouwer C, Meyer S, Burggraaf MJ, Jose J, Molthoff CF (2016) A multimodal imaging approach for longitudinal evaluation of bladder tumor development in an orthotopic murine model. PLoS One 11:e0161284
Schröder L, Lowery TJ, Hilty C, Wemmer DE, Pines A (2006) Molecular imaging using a targeted magnetic resonance hyperpolarized biosensor. Science 20:446–469
Schroeder R-J, Bostanjoglo M, Rademaker J, Maeurer J, Felix R (2003) Role of power Doppler techniques and ultrasound contrast enhancement in the differential diagnosis of focal breast lesions. Eur Radiol 13:68–79
Seimbille Y, Phelps ME, Czernin J, Silverman DHS (2005) Fluorine-18 labeling of 6,7-disubstituted anilinoquinazoline derivatives for positron emission tomography (PET) imaging of tyrosine kinase receptors: synthesis of18F-Iressa and related molecular probes. J Label Compd Radiopharm 61:42–53
Shariati F, Aryana K, Fattahi A, Forghani MN, Azarian A, Zakavi SR, Sadeghi R, Ayati N, Sadri K (2014) Diagnostic value of 99mTc-bombesin scintigraphy for differentiation of malignant from benign breast lesions. Nucl Med Commun 35:620–625
Slomka PJ, Pan T, Germano G (2016) Recent advances and future Progress in PET instrumentation. Semin Nucl Med 46:5–19
Stoffels I, Morscher S, Helfrich I, Hillen U, Leyh J, Burton NC, Sardella TC, Claussen J, Poeppel TD, Bachmann HS (2015) Metastatic status of sentinel lymph nodes in melanoma determined noninvasively with multispectral optoacoustic imaging. Sci Transl Med 7:317ra199-317ra199
Tarkin JM, Dweck MR, Rudd JHF (2018) Imaging as a surrogate marker of drug efficacy in cardiovascular disease. Heart 105:567–578
Thummuri D, Naidu VGM, Chaudhari P (2017) Carnosic acid attenuates RANKL-induced oxidative stress and osteoclastogenesis via induction of Nrf2 and suppression of NF-kappaB and MAPK signalling. J Mol Med (Berl) 95:1065–1076
Toumia Y, Cerroni B, Trochet P, Lacerenza S, Oddo L, Domenici F, Paradossi G (2018) Performances of a pristine graphene–microbubble hybrid construct as dual imaging contrast agent and assessment of its biodistribution by photoacoustic imaging. Part Part Syst Charact 37:1800066
Tuncbilek N, Kaplan M, Altaner S, Atakan IH, Süt N, Inci O, Demir MK (2009) Value of dynamic contrast-enhanced MRI and correlation with tumor angiogenesis in bladder cancer. Am J Roentgenol 192:949–955
Valtorta S, Belloli S, Sanvito F, Masiello V, Di Grigoli G, Monterisi C, Fazio F, Picchio M, Moresco RM (2013) Comparison of 18F-Fluoroazomycin-Arabinofuranoside and 64Cu-diacetyl-Bis(N4-Methylthiosemicarbazone) in preclinical models of Cancer. J Nucl Med 54:1106–1112
Van De Wiele C, Oltenfreiter R, De Winter O, Signore A, Slegers G, Dierckx R (2002) Tumour angiogenesis pathways: related clinical issues and implications for nuclear medicine imaging. Eur J Nucl Med 29:699–710
Van Den Abbeele AD, Badawi RD (2002) Use of positron emission tomography in oncology and its potential role to assess response to imatinib mesylate therapy in gastrointestinal stromal tumors (GISTs). Eur J Cancer 38:S60–S65
Vaneycken I, Govaert J, Vincke C, Caveliers V, Lahoutte T, De Baetselier P, Raes G, Bossuyt A, Muyldermans S, Devoogdt N (2010) In vitro analysis and in vivo tumor targeting of a humanized, grafted nanobody in mice using pinhole SPECT/Micro-CT. J Nucl Med 51:1099–1106
Vergez S, Delord JP, Thomas F, Rochaix P, Caselles O, Filleron T, Brillouet S, Canal P, Courbon F, Allal BC (2010) Preclinical and clinical evidence that deoxy-2-[18F]fluoro-D- glucose positron emission tomography with computed tomography is a reliable tool for the detection of early molecular responses to erlotinib in head and neck cancer. Clin Cancer Res 16:4434–4445
Vogel CL, Cobleigh MA, Tripathy D, Gutheil JC, Harris LN, Fehrenbacher L, Slamon DJ, Murphy M, Novotny WF, Burchmore M, Shak S, Stewart SJ, Press M (2002) Efficacy and safety of Trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast Cancer. Clin Oncol 20:719–729
Wagner N, Eldar YC, Friedman Z (2012) Compressed beamforming in ultrasound imaging. IEEE Trans Signal Process 60:4643–4657
Walter MA, Hildebrandt IJ, Hacke K, Kesner AL, Kelly O, Lawson GW, Phelps ME, Czernin J, Weber WA, Schiestl RH (2010) Small-animal PET/CT for monitoring the development and response to chemotherapy of thymic lymphoma in Trp53-/- mice. J Nucl Med 51:1285–1292
Wang LV, Yao J (2016) A practical guide to photoacoustic tomography in the life sciences. Nat Methods 13:627
Weber J, Beard PC, Bohndiek SE (2016) Contrast agents for molecular photoacoustic imaging. Nat Methods 13:639
Willmann JK, Van Bruggen N, Dinkelborg LM, Gambhir SS (2008) Molecular imaging in drug development. Nat Rev Drug Discov 7:591–606
Wu P, Zhang Y, Sun Y, Shi X, Li F, Zhu Z (2013) Clinical applications of 18F-FDG PET/CT in monitoring anti-cancer therapies. Curr Pharm Biotechnol 14(7):658–668
Xu M, Wang LV (2006) Photoacoustic imaging in biomedicine rev. Sci Instrum 77:041101
Xu Z, Li XF, Zou H, Sun X, Shen B (2017)18F-Fluoromisonidazole in tumor hypoxia imaging. Oncotarget 8:94969–94979
Xuan JW, Bygrave M, Jiang H, Valiyeva F, Dunmore-Buyze J, Holdsworth DW, Izawa JI, Bauman G, Moussa M, Winter SF, Greenberg NM, Chin JL, Drangova M, Fenster A, Lacefield JC (2007) Functional neoangiogenesis imaging of genetically engineered mouse prostate cancer using three-dimensional power doppler ultrasound. Cancer Res 67:2830–2839
Yang J, Guo H, Gallazzi F, Berwick M, Padilla RS, Miao Y (2009) Evaluation of a novel Arg-Gly-Asp-conjugated α-melanocyte stimulating hormone hybrid peptide for potential melanoma therapy. Bioconjug Chem 19:1634–1642
Zeng Q, Yang Z, Gao YJ, Yuan H, Cui K, Shi Y, Wang H, Huang X, Wong STC, Wang Y, Kesari S, Ji RR, Xu X (2010) Treating triple-negative breast cancer by a combination of rapamycin and cyclophosphamide: An in vivo bioluminescence imaging study. Eur J Cancer 46:1132–1143
Zhu G, Li H, Zhang Y, Li Y, Liang S, Liu J (2011) Concomitant pulmonary and thyroid tumors identified by FDG PET/CT and immunohistochemical techniques. World J Surg Oncol 9(1):119
Acknowledgements for Sect. 17.17
-
(a)
MARS Collaboration and MARS Bioimaging Ltd.
-
(b)
Ministry of Business, Innovation and Employment (MBIE), New Zealand, for funding (UOCX1404) through the MedTech CoRE.
-
(c)
CERN and the Medipix2, Medipix3 and Medipix4 collaborations.
Author information
Authors and Affiliations
Consortia
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Kumar, P. et al. (2019). Preclinical Non-invasive Imaging in Cancer Research and Drug Discovery: An Overview. In: Bose, K., Chaudhari, P. (eds) Unravelling Cancer Signaling Pathways: A Multidisciplinary Approach. Springer, Singapore. https://doi.org/10.1007/978-981-32-9816-3_17
Download citation
DOI: https://doi.org/10.1007/978-981-32-9816-3_17
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-32-9815-6
Online ISBN: 978-981-32-9816-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)